Submit your email to push it up the queue
Bioquell Limited, headquartered in Great Britain, is a leading provider of innovative bio-decontamination solutions. Founded in 1997, the company has established itself within the healthcare and pharmaceutical industries, focusing on infection control and environmental decontamination. Bioquell's core offerings include its unique hydrogen peroxide vapour technology, which effectively eliminates harmful pathogens in critical environments. This advanced method sets Bioquell apart, ensuring compliance with stringent regulatory standards and enhancing patient safety. With a strong presence in Europe and expanding operations globally, Bioquell has achieved significant milestones, including partnerships with major healthcare institutions. The company is recognised for its commitment to quality and innovation, solidifying its position as a trusted leader in bio-decontamination solutions.
How does Bioquell Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bioquell Limited's score of 91 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bioquell Limited, headquartered in Great Britain, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Ecolab Inc., and any climate commitments or emissions data may be influenced by initiatives from its parent organization. As part of its corporate family relationship with Ecolab Inc., Bioquell Limited may align with the sustainability and climate strategies set forth by Ecolab, which includes various reduction initiatives. However, specific reduction targets or achievements for Bioquell Limited are not detailed in the available information. Bioquell Limited's climate commitments may be informed by Ecolab's broader sustainability goals, including participation in initiatives such as the Science Based Targets initiative (SBTi) and the CDP. These initiatives aim to drive significant reductions in greenhouse gas emissions across their operations. In summary, while Bioquell Limited does not currently report specific emissions data or reduction targets, it is positioned within a corporate structure that prioritises sustainability and climate action through its relationship with Ecolab Inc.
Access structured emissions data, company-specific emission factors, and source documents
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 398,038,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 238,327,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | 60,321,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bioquell Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.